tirzepatide off shortage list FDA reconsidering its decision to take its drug FDA's GLP-1 decision kicks off

VLDL receptor gene therapy for reducing atherogenic lipoproteins

We created a side-by-side comparison of bariatric surgery and GLP-1 medications for easy reference

The cost of prevention is always lower than the cost of failed studies

Clinical trials such as the Semaglutide Treatment Effect in People with Obesity (STEP) trials have consistently shown that Semaglutide treatment leads to significant reductions in body weight, body mass index (BMI), and visceral adiposity compared to placebo

Understanding these fundamental mechanisms provides context for evaluating their potential effects on urinary function and fluid balance

Others have had some luck with antacids and fiber supplements